The landscape of the American pharmaceutical industry underwent a significant structural shift on September 29, 2026, as the federal government…
Read More
Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure
The landscape of American pharmaceutical manufacturing is undergoing a seismic shift as the U.S. government implements a aggressive trade policy…
Read MorePharma tariffs reach smaller drugmakers as industry warns of R&D pressure
The landscape for pharmaceutical manufacturing in the United States underwent a seismic shift on September 29, as federal tariffs on…
Read More
Pharma tariffs reach smaller drugmakers as industry warns of R&D pressure
The landscape for pharmaceutical manufacturing in the United States underwent a significant shift on September 29, 2026, as the scope…
Read More
US President Donald Trump Plans to Introduce Steep Tariffs on Imported Generic Pharmaceuticals
Following a period of relative exemption from escalating trade tensions, the global generic pharmaceutical industry is now facing the prospect…
Read More
US Import Tariffs Fail to Deter Biopharma Giants as European Contract Manufacturing Surges for FDA-Approved Drugs
The biopharmaceutical industry is demonstrating a significant and counterintuitive trend in 2025, with companies increasingly channeling investments into European-based contract…
Read More
